A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia (Q33345998)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia |
scientific article |
Statements
1 reference
A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia (English)
1 reference
Ayalew Tefferi
1 reference
Ruben A Mesa
1 reference
Animesh Pardanani
1 reference
Chin-Yang Li
1 reference
Michelle Elliott
1 reference
Scott H Kaufmann
1 reference
Gregory Wiseman
1 reference
Leigh A Gray
1 reference
Georgene Schroeder
1 reference
Terra Reeder
1 reference
Jerome B Zeldis
1 reference
27 November 2002
1 reference
Identifiers
1 reference